Photo by Judit Peter via Pexels The submission deadline for the 4th annual short essay competition  on the topic of Inclusivity, Diversity and Equity in Dermatology is Dec. 4, 2025.   The contest is open to any qualified resident enrolled in a dermatology training program at a Canadian medical school. This essay competition is organized by the Dermatology Industry Taskforce on Inclusion, Diversity and Equity (DiTiDE), an unincorporated, "ad hoc" committee consisting of Canadi

Yu-Ying He, PhD. Photo courtesy the University of Chicago In a new study published in Nature Communications , researchers at the University of Chicago have discovered how prolonged exposure to ultraviolet (UV) radiation can trigger inflammation in skin cells by degrading a key protein called YTHDF2. This protein acts as a gatekeeper in preventing normal skin cells from becoming cancerous. The finding reveals that YTHDF2 plays a crucial role in regulating RNA metabolism to mai

Whether AD patients bathe weekly or daily has no impact on their symptoms.

Photo by Care_SMC via Flickr The timing, duration, and severity of eczema in early life may significantly influence whether children outgrow food allergies, according to findings presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Orlando, Fla. “Food allergy and eczema often appear together in childhood, but scientists don’t fully understand how one condition affects the other,” said Nicole Koulov, in a press release . She

Atopic dermatitis. Photo by AfroBrazilian via Wikimedia Commons Two new studies presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) show that people with eczema or allergic conditions may face more problems after certain types of surgery. The research suggests that the inflammation and immune system changes that come with these conditions can make it harder for the body to heal and may increase the risk of infectio

CO2 laser treatment significantly improved quality of life in patients with hidradenitis suppurativa

The FPR1-inhibitory activity of the candidate compounds was evaluated using an in vitro SJS/TEN assay. Cell death inhibition was assessed by live/dead staining following treatment with various concentrations of each compound. Among the seven candidates, CDCA exhibited a specific and potent inhibitory effect on cell death, even at low concentrations. Image modified from Kimura H et al., Nat Commun . 2025. A Japanese research group has identified a promising therapeutic candida

Epidermolysis bullosa simplex. Photo by James Heilman, MD, via Wikimedia Commons Researchers have developed the first disease-specific clinical tool to assess the severity of epidermolysis bullosa simplex (EBS), according to a study recently published in JAMA Dermatology . EBS is the most common subtype of epidermolysis bullosa. Despite its prevalence, there is no U.S. Food and Drug Administration-approved treatment for EBS, and clinicians have lacked a standardized method fo